HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Clean Air labeling

This article was originally published in The Rose Sheet

Executive Summary

California Air Resources Board will consider developing Clean Air Labeling Program as incentive for manufacturers to develop lower gas emitting products, agency says. Label would be awarded to qualifying products to inform consumers of reduced air pollution impact, CARB adds. Agency will hold public meeting April 19 in Sacramento to discuss proposal. Clean Air Plan is in development by CARB to reduce reactive gas emissions including voluntary organic compounds found in personal care products (1"The Rose Sheet" March 25, 2002, p. 3)...

You may also be interested in...



Clean Air Labeling

California Air Resources Board postpones review of proposed Clean Air Labeling Program to gather additional data, agency says. Labeling initiative was slated to be discussed at board's July meeting, but may be rescheduled later in the year, CARB states. Agency announced consideration of Clean Air Labeling Program as incentive for manufacturers to develop lower VOC emitting products as part of its Clean Air Plan, which was withdrawn early this year for reworking. Label would be awarded to qualifying products to inform consumers of reduced air pollution impact (1"The Rose Sheet" April 15, 2002, In Brief)...

CARB VOC Limits In Additional Personal Care Categories Outlined In Plan

The California Air Review Board should consider evaluating additional personal care product categories for possible reductions in reactive organic gas emissions, according to a proposed comprehensive Clean Air Plan released March 15

Seretide Settlement To Lift Glenmark’s Europe Business

Glenmark can sell its partnered generic rival to GSK’s Seretide Accuhaler dry powder inhaler in certain European markets following a settlement with the UK company. The Indian firm has also shelved divestment plans for its API business, at least for now.

UsernamePublicRestriction

Register

RS010197

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel